{"id":"W2765660745","doi":"10.1111/1755-5922.12308","title":"Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Tolerability; PCSK9; Placebo; Internal medicine; Clinical endpoint; Gastroenterology; Statin; Adverse effect; Kexin; Endocrinology; Urology; Pharmacology; Randomized controlled trial; Lipoprotein; Cholesterol; LDL receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005911672,0.0009564584,0.001875144,0.000179764,0.000323471,0.0003583031,0.0003983135,0.001043861,0.002761319],"category_scores_gemma":[0.0009003318,0.0003896217,0.0008467888,0.0001686367,0.0004684959,0.0003243054,0.0002272181,0.001638434,0.0004789721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003192836,"about_ca_system_score_gemma":0.0005699649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00167262,"about_ca_topic_score_gemma":0.002835731,"domain_scores_codex":[0.9997749,0.00008836293,0.00001485984,0.00003815244,0.00001786998,0.00006589687],"domain_scores_gemma":[0.9994503,0.0001198988,0.00008163686,0.00004196675,0.00003695272,0.0002692973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8231368,0.05300051,0.004602648,0.0004671612,0.0006117892,0.0002135125,0.0001682212,0.001012731,0.05280291,0.00004511062,0.001137775,0.06280073],"study_design_scores_gemma":[0.1557427,0.7466106,0.07887567,0.00009289361,0.000930912,0.0002368545,0.0001078666,0.001819888,0.01378099,0.00008480797,0.001663143,0.00005352266],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997667,0.0009265709,0.0001354175,0.0001236528,0.000101871,0.0001765885,0.0001904096,0.00004131384,0.0006371144],"genre_scores_gemma":[0.9966037,0.0005577746,0.0002973935,0.0001563707,0.00008425427,0.0002671968,0.0003432688,0.000007428988,0.00168249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002761319,"threshold_uncertainty_score":0.009237468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03117708978944782,"score_gpt":0.2941826839491778,"score_spread":0.26300559415973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}